Glaukos Corporation to Release First Quarter 2017 Financial Results after Market Close on May 3
April 19 2017 - 7:00AM
Business Wire
Conference Call and Webcast Scheduled for 1:30
p.m. PDT
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical
technology company focused on the development and commercialization
of breakthrough products and procedures designed to transform the
treatment of glaucoma, plans to release first quarter 2017
financial results after the market close on Wednesday, May 3, 2017.
The company’s management will discuss the results during a
conference call and simultaneous webcast at 1:30 p.m. PDT (4:30
p.m. EDT) on May 3, 2017.
A link to the live webcast will be available on the company’s
website at http://investors.glaukos.com. To participate in the
conference call, please dial 877-201-0168 (U.S.) or 647-788-4901
(International) and enter Conference ID 4368346. A replay will be
archived on the company’s website following completion of the
call.
About Glaukos
Glaukos (www.glaukos.com) is an ophthalmic medical technology
company focused on the development and commercialization of
breakthrough products and procedures to transform the treatment of
glaucoma, one of the world’s leading causes of blindness. The
company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to
revolutionize the traditional glaucoma treatment and management
paradigm. Glaukos launched the iStent® Trabecular Micro-Bypass
Stent, its first MIGS device, in the United States in July 2012 and
is leveraging its platform technology to build a comprehensive and
proprietary portfolio of micro-scale injectable therapies designed
to address the complete range of glaucoma disease states and
progression. The company believes the iStent, which measures 1.0 mm
long and 0.33 mm wide, is the smallest medical device ever approved
by the FDA.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170419005372/en/
Glaukos CorporationSheree AronsonVP, Investor Relations(949)
367-9600 ext 371saronson@glaukos.com
Glaukos (NYSE:GKOS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Glaukos (NYSE:GKOS)
Historical Stock Chart
From Sep 2023 to Sep 2024